Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Bloomberg
Bloomberg
Business
Marthe Fourcade

AstraZeneca to Buy ZS Pharma for $2.7 Billion in Cash Deal

AstraZeneca Plc, the U.K.’s second-largest drugmaker, agreed to buy ZS Pharma of California for $2.7 billion in cash to gain a potential blockbuster medicine for a deadly condition.

ZS Pharma holders will get $90 per share, London-based AstraZeneca said in a statement. ZS Pharma’s board agreed to the transaction.

To contact the reporter on this story: Marthe Fourcade in Paris at mfourcade@bloomberg.net To contact the editors responsible for this story: Chitra Somayaji at csomayaji@bloomberg.net David Whitehouse

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.